*** Welcome to piglix ***

Flutamide

Flutamide
Flutamide.svg
Flutamide ball-and-stick.png
Clinical data
Trade names Eulexin, others
AHFS/Drugs.com Monograph
MedlinePlus a697045
Pregnancy
category
  • D
Routes of
administration
By mouth
ATC code L02BB01 (WHO)
Legal status
Legal status
  • ℞ (Prescription only)
Pharmacokinetic data
Bioavailability >90%
Protein binding 94 to 96%
Biological half-life 8 hours (for 2-hydroxyflutamide)
Excretion >90% via urine
Identifiers
Synonyms Niftolide; SCH-13521; 4'-nitro-3'-trifluoromethylisobutyranilide
CAS Number 13311-84-7 YesY
PubChem (CID) 3397
IUPHAR/BPS 6943
DrugBank DB00499 YesY
ChemSpider 3280 YesY
UNII 76W6J0943E YesY
KEGG D00586 YesY
ChEBI CHEBI:5132 YesY
ChEMBL CHEMBL806 YesY
ECHA InfoCard 100.033.024
Chemical and physical data
Formula C11H11F3N2O3
Molar mass 276.212 g/mol
3D model (Jmol) Interactive image
Melting point 111.5 to 112.5 °C (232.7 to 234.5 °F)
  

Flutamide, sold under the brand name Eulexin among others, is a synthetic, non-steroidal antiandrogen (NSAA) used primarily to treat prostate cancer. It acts as a selective antagonist of the androgen receptor (AR), competing with androgens such as testosterone and its powerful active metabolite dihydrotestosterone (DHT) for binding to ARs in the prostate gland. By doing so, it prevents them from stimulating the prostate cancer cells to grow. In addition to its use in prostate cancer, flutamide has been used to treat hyperandrogenism (excess androgen levels) in women, such as in those with polycystic ovary syndrome (PCOS), and hirsutism. Flutamide has been largely replaced by newer NSAAs, namely bicalutamide and enzalutamide, due particularly to better safety, tolerability, and pharmacokinetic profiles.

GnRH is released by the hypothalamus in a pulsatile fashion; this causes the anterior pituitary gland to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH stimulates the testes to produce testosterone, which is metabolized to DHT by the enzyme 5α-reductase.


...
Wikipedia

...